Orthofix and CGBio Pair Up for Novosis rhBMP-2 Bone Graft Solutions

illustration biologic matrix orange

Orthofix Medical entered into a strategic partnership agreement with CGBio to develop and commercialize Novosis™ recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials and other future tissue regenerative solutions for the U.S. and Canadian markets.

Orthofix will conduct clinical studies, obtain regulatory approvals and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us